Treos Bio

London, United Kingdom

Treos Bio, Inc. develops precision cancer immunotherapies tailored to patients' genetics.

$2.1M raised

Aug 2025

Convertible Note

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Treos Bio raised?

Treos Bio has raised $2.1M in total funding. The most recent round was Convertible Note. The last funding was announced in August 2025.

Who are Treos Bio's investors?

Treos Bio's investors include The Future Fund, Luminous Ventures, BXR Partners LLP.

Where is Treos Bio headquartered?

Treos Bio is headquartered in London, United Kingdom.

What does Treos Bio do?

Treos Bio, Inc. develops precision cancer immunotherapies tailored to patients' genetics.

What stage is Treos Bio at?

Treos Bio is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 27, 2025.

MLA

"Treos Bio — Funding & Investors." VCBacked, August 27, 2025, https://www.vcbacked.co/company/treos-bio. Accessed July 3, 2026.

APA

VCBacked. (2025). Treos Bio — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/treos-bio

Wikipedia (cite web)

{{cite web |title=Treos Bio — Funding & Investors |url=https://www.vcbacked.co/company/treos-bio |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 27, 2025.